The road ahead: potential challenges facing CRISPR/Cas patents

Since Anton van Leeuwenhoek first discovered bacteria, these tiny single-cell organisms have been pivotal to major scientific advances. In fact, some of the biggest advances in medicine can be attributed to these unicellular microorganisms.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

US warns of rising counterfeit drug threat from India and China

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

Biotech and healthcare expert returns to Latham & Watkins

Commercialising genomic tech in Nigeria

Why US patent reform is ‘essential’ for US economic prosperity and security

Medical company sees $452m trade secrets award cut by 87%

Fed Circ: Generic doesn’t infringe Metacel MS drug

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO

The road ahead: potential challenges facing CRISPR/Cas patents

Editor's picks

Editor's picks

More features